Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-21 4:04 pm Purchase | 2025-01-14 | 13G | ANI Pharmaceuticals, Inc. ANIP | MILLENNIUM MANAGEMENT LLC | 1,091,003 5.200% | 1,091,003 (New Position) | Filing History |
| 2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP | Rubric Capital Management LP | 56,671 0.270% | -1,068,329 (-94.96%) | Filing History |
| 2024-03-14 07:30 am Sale | 2024-03-12 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 1,444,570 6.900% | -232,855 (-13.88%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | ANI Pharmaceuticals, Inc. ANIP | VANGUARD GROUP INC | 1,288,972 6.310% | 1,288,972 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | Rubric Capital Management LP | 1,125,000 5.510% | 1,125,000 (New Position) | Filing History |
| 2024-01-23 4:13 pm Purchase | 2023-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 2,524,660 12.400% | 541,423 (+27.30%) | Filing History |
| 2024-01-17 07:45 am Sale | 2023-12-18 | 13D | ANI Pharmaceuticals, Inc. ANIP | Esjay LLC | 985,027 4.800% | -50,000 (-4.83%) | Filing History |
| 2023-12-18 5:18 pm Sale | 2023-12-14 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 1,677,425 8.200% | -190,855 (-10.22%) | Filing History |
| 2023-12-05 4:30 pm Sale | 2023-11-17 | 13D | ANI Pharmaceuticals, Inc. ANIP | Esjay LLC | 1,035,027 5.070% | -311,053 (-23.11%) | Filing History |
| 2023-08-17 6:22 pm Sale | 2023-08-16 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 1,868,280 9.200% | -200,000 (-9.67%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 1,983,237 11.400% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 1,983,237 11.400% | 296,624 (+17.59%) | Filing History |
| 2022-12-12 4:00 pm Purchase | 2022-12-01 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 2,068,280 11.800% | 2,068,280 (New Position) | Filing History |
| 2022-03-02 4:30 pm Purchase | 2021-11-19 | 13D | ANI Pharmaceuticals, Inc. ANIP | Esjay LLC | 1,346,080 8.040% | 1,346,080 (New Position) | Filing History |
| 2022-02-07 4:41 pm Purchase | 2021-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 1,686,613 11.800% | 97,385 (+6.13%) | Filing History |
| 2021-01-26 6:52 pm Purchase | 2020-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 1,589,228 12.900% | 41,479 (+2.68%) | Filing History |